Breaking News from BioNeutral
BioNeutral Announces Major Sales Milestone Achievement 

Good morning team!  Earlier today I put out a quick report on BONU discussing the growth of its sales and distribution chain over the past few months.  In January, BioNeutral announced that it had entered into an agreement with Quip Laboratories and moved into the market segments of laboratory animal research and biomedical research.  Today the company came out with a block buster announcement that Quip Laboratories (Quip) has made great strides in the product launch process of BioNeutral’s YGIENE 206 and OGIENE Odor Eliminator.

In addition to conducting sales training during its “QUIP University”, Quip Labs has also initiated a recent product awareness campaign that began April 4.  Quip is utilizing direct email to generate immediate exposure and rapid interest, nationally, for YGIENE 206 as one of its exciting new products for 2014.

“YGIENE 206 has already been enthusiastically received by our clients in the Biomedical Research and Laboratory Animal Research sectors…we see this as both a market disrupter, and game changer, in terms of client acquisition across several sectors we’re targeting for expansion in 2014,” reports Nick Hidell, product manager for QUIP.

I think this is very exciting news and could be a strong catalyst for a potential breakout from BONU.  In fact the last time we covered this company on a day of news, the stock ran to highs of .0014 with a 55PCT run from the open.  After seeing all of the recent accumulation around the .0008 level these past few days, I think there could be even more opportunity for a momentum run heading into today.  Pull up BONU, read this morning’s news and let’s get ready for the open!

Thanks for reading and good luck trading,

The Staff at Investor News Source

Don’t ever invest based on what I say.  Do your own research and consult with a licensed profession before investing.  Any statements and opinions given are amateur and biased and should be treated as such.  Past performance does not indicate future performance in any way.  The performance of all alerts uncompensated and compensated in no way predict the performance of current and/or upcoming alerts.  Check the latest SEC filings before investing, and research other information on the risks of investing in microcap companies at  For important information concerning this email, including applicable disclaimers, compensation consideration, and additional information please make sure to read the information contained within. Investor News Source has been compensated seven thousand dollars and eleven million shares of BioNeutral stock restricted pursuant to rule 144 for at least a six month period beginning Dec 19,2013 by the company for 1 day of coverage on BioNeutralGroup Inc.  Once mature, the intent is to sell these in the open market at fair market value which could negatively effect price. To view our full disclaimer, click HERE.

Tags: , , , , , , , , , ,


Investor News Source is a destination website for traders and investors to see and review up to the minute press releases from OTC companies provided by Nasdaq and globe wire. Investor News Source provides traders with a way to search trades by PR and not by symbol first. It can change the way you trade. Follow us and see for your self!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: